Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions.
Kyoko OchiaiHiroki ShimaToru TamaharaNao SugieRyo FunayamaKeiko NakayamaTomohiro KurosakiKazuhiko IgarashiPublished in: The EMBO journal (2024)
Transcription factors BACH2 and IRF4 are both essential for antibody class-switch recombination (CSR) in activated B lymphocytes, while they oppositely regulate the differentiation of plasma cells (PCs). Here, we investigated how BACH2 and IRF4 interact during CSR and plasma-cell differentiation. We found that BACH2 organizes heterochromatin formation of target gene loci in mouse splenic B cells, including targets of IRF4 activation such as Aicda, an inducer of CSR, and Prdm1, a master plasma-cell regulator. Release of these gene loci from heterochromatin in response to B-cell receptor stimulation was coupled to AKT-mTOR pathway activation. In Bach2-deficient B cells, PC genes' activation depended on IRF4 protein accumulation, without an increase in Irf4 mRNA. Mechanistically, a PU.1-IRF4 heterodimer in activated B cells promoted BACH2 function by inducing gene expression of Bach2 and Pten, a negative regulator of AKT signaling. Elevated AKT activity in Bach2-deficient B cells resulted in IRF4 protein accumulation. Thus, BACH2 and IRF4 mutually modulate the activity of each other, and BACH2 inhibits PC differentiation by both the repression of PC genes and the restriction of IRF4 protein accumulation.
Keyphrases
- dendritic cells
- genome wide
- gene expression
- cell proliferation
- transcription factor
- signaling pathway
- genome wide identification
- dna methylation
- binding protein
- immune response
- induced apoptosis
- single cell
- oxidative stress
- bone marrow
- cell therapy
- small molecule
- mass spectrometry
- atomic force microscopy
- single molecule